CONTINUING EDUCATION - Spring 2025
LSU Health Department of Medical Laboratory Science is approved as a provider of continuing education programs in the clinical laboratory sciences by the Clinical Laboratory Personnel Committee (CLPC) of the Louisiana State Board of Medical Examiners (LSBME). These seminars are offered FREE only for individuals who hold a CURRENT Louisiana CLP license. They are also accepted for BOC Credential Maintenance Program (CMP) credit by the ASCP Board of Certification.
CE sessions will be provided live via Zoom one time with the presenter. Participants will have the opportunity to ask questions after the seminar. Each session will be recorded during the live presentation and posted on CE Broker for use on-demand at a later date. To obtain CE credit for on-demand seminars, participants will be required to take a post-test based on the seminar. Previously recorded seminars can be found here.
Please click on the registration link for each session you plan to attend below. Information about the presenters’ topics and objectives can be found here.
You MUST pre-register for each live session you plan to attend via Zoom.
- You will need to have a Zoom account in order to register for these sessions. If you do not have a Zoom account, you can sign up for free by going here. Once you have signed in your Zoom account, submit your registration by entering your full name, e-mail address, and LA license number. PLEASE ENTER YOUR LA LICENSE NUMBER AS IT APPEARS ON YOUR CARD/ACCOUNT! (For example, CLP.G09991-GEN, CLP.L09991-LAB, 390132, ETC).
- You will receive an e-mail with the Zoom information for each session for which you registered. BE SURE TO SAVE THIS E-MAIL, AS IT CONTAINS THE WEBLINK, SESSION NUMBER, AND PASSWORD REQUIRED TO BE ADMITTED INTO THE ZOOM SESSION.
- Be sure you have downloaded the Zoom application to your computer, tablet, or smartphone PRIOR TO THE DATE OF THE SESSION. You can find more information about Zoom here. You can also download the Zoom app from the Google Play store (PC/Android) as well as the App store (Apple).
- NOTE: Unfortunately, Zoom limits each session to 300 attendees. Please register early as registrations will be taken on a first-come, first-served basis. If you register and decide not to attend the session, please e-mail us at CLPC@lsuhsc.edu to cancel your registration as we may have a waiting list for that session.
On the day of the session, please use the weblink and password from your registration e-mail to access the Zoom meeting. When you login, you will be placed into a waiting room and then be admitted into the Zoom meeting by LSUHSC. We will begin the session at the scheduled time. In order to qualify for CE credit, you must be in attendance within the first 20 minutes after the session has begun. As a reminder CE certificates will NOT be printed, mailed, or e-mailed directly to participants! CE credits will be submitted to CE Broker on your behalf. You will receive notification from CE Broker once the CE credit has been posted to your account.
Date and Times |
Speaker & Topic |
Registration link |
Description |
Objectives |
Level of Presentation |
| 4/14/2025 10-1130am | Stephanie Blackburn, EdD, MLS(ASCP)cm Confronting the Global Threat of Antimicrobial Resistance |
This presentation explores the rising threat of antimicrobial resistance and the impact on public health. It emphasizes mechanisms of resistance, factors that contribute to antimicrobial resistance, and current initiatives to reduce this ongoing threat. | 1. Describe a variety of mechanisms that cause antimicrobial resistance. 2. Explore the impact of antimicrobial resistance on public health. 3. Discuss current initiatives to combat antimicrobial resistance. | Advanced | |
| 4/17/2025 1-230pm |
Kristin Butler, MPH, MLS(ASCP)cm |
Link | This presentation will discuss a recently published case report of an elderly male who develops severe post-transfusion purpura (PTP) after being treated for cardiogenic shock. | 1. Characterize the rare adverse condition of post-transfusion purpura (PTP). 2. Discuss the development of alloantibodies to human platelet antigens (HPAs). 3. Describe diagnosis, treatment, and management strategies for controlling PTP. | Intermediate |
| 4/24/2025 10-1130am | Alexa Little, MBEC, MLS(ASCP)cm CLIA 2025: Navigating New Personnel Qualifications & Regulations |
Link | This seminar provides an in-depth overview of the 2025 CLIA regulatory updates, including revised personnel qualifications and new laboratory requirements. Attendees will gain clarity on compliance changes and have the opportunity to address regulatory concerns through an interactive Q&A session. | 1. Detail recent CLIA regulatory changes, including updates to personnel qualifications and additional laboratory requirements. 2. Provide clarity on compliance expectations to ensure adherence to the latest CLIA standards. 3. Address regulatory and compliance-related questions through an interactive Q&A session. | Intermediate |
| 4/28/2025 2-330pm | Lauren Ashcraft, MLS(ASCP) Adrenal Gland Disorders: Addison's and Cushing's |
Link | An overview of the adrenal glands: location, hormones produced, Addison's disease, and Cushing's disease. | 1. Identify the hormones produced by the adrenal glands. 2. Describe Addison's disease. 3. Describe Cushing's disease. | Basic |
| 4/30/2025 1-230pm | Lee Ellen Brunson, MHS, MLS(ASCP)CM Achy Breaky Heart: A Look Stress-Induced Cardiomyopathy |
Link | Stress-induced cardiomyopathy, also known as broken heart syndrome, is a typically-temporary heart condition often triggered by extreme stress or emotional events.This presentation will discuss the suspected causes, symptoms, diagnosis, and treatment of stress-induced cardiomyopathy. | 1. Describe the clinical presentation of stress-induced cardiomyopathy. 2. Discuss suspected causes of stress-induced cardiomyopathy. 3. Explain how symptoms, testing, and the exclusion of other conditions are used to diagnose and monitor this condition. | Intermediate |
| 5/13/2025 1-230pm | Grace Athas, PhD, MLS(ASCP)CM Vaccines: evidence-based medicine and societal perceptions |
Link | Immunization is a cornerstone of public health that has saved countless lives, prevented numerous diseases, and significantly improved the overall quality of life for people around the world. Social media has amplified vaccine misinformation over the past decade, leading to outbreaks and deaths from vaccine-preventable diseases. We will discuss the science behind vaccine technology, successes, and the history of misinformation leading to vaccine hesitancy. | 1. Identify and Recognize Vaccine History and Fallacies. 2. Identify and summarize childhood and adult vaccine schedules and the scientific basis of these vaccines. 3. 3. Identify and review current and future vaccine technology. | Intermediate |
| 5/16/2025 11am-1230pm | Christen Diel, MS, MLS(ASCP) DCLS Driven Laboratory Utilization for Specimen Referral Testing |
Link | Send-Out testing can drive up significant costs and resources. WellstarMCG has developed a Utilization Review process to mitigate these wastes through a targeted review of high-cost or often misutilized tests. Our resident-led clinical assessments ensure clinically necessity, pioneering a more cost-effective and patient-centered approach to laboratory testing. | 1. Identify key stakeholders and members of a lab utilization team. 2. Distinguish the possible decision end-points based on the case review. 3. Summarize the flow of information according to the Specimen Referral Utilization Review Process. | Intermediate |
| 6/4/2025 11am-1230pm | Christen Diel, MS, MLS(ASCP) Hidden Infections: The Organisms You Might Not See (Microbiology Case Studies) |
Link | Two-Three microbiology case reports that were not easily detected using conventional laboratory testing. Cases include Naegleri Fowleri, Capnocytophaga bactermia, and Coxsackie Virus complicated by Rhabdomyolysis in adult. | 1. Identify risk factors and pathogens that may cause meningoencephalopthy in previously healthy teenager. 2. Analyze laboratory data and clinical history to postulate a source of infection in a hospitalized patient with complicated presentation. 3. Differentiate potential infectious agents that are associated with sever rhabdomyolysis. |